We are very happy to confirm that we finally have finding from the NIHR and MRC to go ahead with the Metformin in Li Fraumeni Syndrome (MILI) trial that we’ve discussed many times over the last few years. This is significant, not just for people with LFS, but for potentially for other groups at high-risk of cancer. We’ll have more information coming up – but for now here’s the exclusive story from today’s Daily Express.
Devon Hansen
This is amazing, I would love to be part of this trial, do you have any information on how we would sign up?
Pan
Hi. Watch this space! We will be working closely with the various centres involved in the study to make sure that we can recruit as many people with LFS as possible. There’s a lot of work still to do to get everything in place – but we will be keeping the community posted as we make progress.
April Rohde
Excellent news. Lost my son and husband to lfs/cancer. My 29 years old son has it too.
Pan
Sorry to hear that – sadly it’s a familiar story that we desperately need to change.